Publications:

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design.

Bmc Genomics

Cai, Weijing W; Zhou, Dapeng D; Wu, Weibo W; Tan, Wen Ling WL; Wang, Jiaqian J; Zhou, Caicun C; Lou, Yanyan Y

Publication Date: 2018-08-03

Variant appearance in text: MUC16: T12805S

PubMed Link: 30075702

Variant Present in the following documents:

• Main text
• 12864_2018_4958_MOESM3_ESM.xlsx, sheet 1
• 12864_2018_4958_MOESM4_ESM.xlsx, sheet 1
• 12864_2018_4958_MOESM5_ESM.xlsx, sheet 1
• 12864_2018_Article_4958.pdf

View BVdb publication page

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Cancer Cell

Hellmann, Matthew D MD; Nathanson, Tavi T; Rizvi, Hira H; Creelan, Benjamin C BC; Sanchez-Vega, Francisco F; Ahuja, Arun A; Ni, Ai A; Novik, Jacki B JB; Mangarin, Levi M B LMB; Abu-Akeel, Mohsen M; Liu, Cailian C; Sauter, Jennifer L JL; Rekhtman, Natasha N; Chang, Eliza E; Callahan, Margaret K MK; Chaft, Jamie E JE; Voss, Martin H MH; Tenet, Megan M; Li, Xue-Mei XM; Covello, Kelly K; Renninger, Andrea A; Vitazka, Patrik P; Geese, William J WJ; Borghaei, Hossein H; Rudin, Charles M CM; Antonia, Scott J SJ; Swanton, Charles C; Hammerbacher, Jeff J; Merghoub, Taha T; McGranahan, Nicholas N; Snyder, Alexandra A; Wolchok, Jedd D JD

Publication Date: 2018-05-14

Variant appearance in text: MUC16: T12805S

PubMed Link: 29657128

Variant Present in the following documents:

• mmc3.xlsx, sheet 3

View BVdb publication page

Genomic alterations in mucins across cancers.

Oncotarget

King, Ryan J RJ; Yu, Fang F; Singh, Pankaj K PK

Publication Date: 2017-09-15

Variant appearance in text: MUC16: T12805S

PubMed Link: 28978023

Variant Present in the following documents:

• oncotarget-08-67152-s005.xls, sheet 1

View BVdb publication page